Testing effectiveness (Phase 2)Study completedNCT00890162
What this trial is testing
A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis
Who this might be right for
AnaphylaxisHypotensionBronchospasm+1 more
National Institute of Allergy and Infectious Diseases (NIAID) 16